Research Article
The Genetic Polymorphisms of NLRP3 Inflammasome Associated with T Helper Cells in Patients with Multiple Myeloma
Table 4
The correlations of the genetic polymorphisms of the NLRP3 inflammasome with clinical features of MM patients.
| | Age | Male : female | Type | DS | ISS | Bone damaged | Hemogram | BM myeloma | IgG | IgA | Light chain (κ + λ) | IgD | IgE | IgM | Nonsecretory type | I | II | III | I | II | III | With | Without | WBC (×109/L) | Hemoglobin (g/L) | Platelet (×109/L) | Cell percentage (%) |
| CARD8-C10X (rs2043211) | AA | 59 (25–80) | 55 : 34 | 44 | 14 | 30 | 1 | 0 | 0 | 0 | 3 | 29 | 57 | 12 | 43 | 34 | 72 | 17 | 5.20 ± 0.28 | 88.95 ± 2.52 | 177.96 ± 8.96 | 34.04 ± 2.40 | AT | 59 (28–89) | 107 : 77 | 78 | 39 | 59 | 5 | 1 | 1 | 1 | 8 | 73 | 35 | 25 | 79 | 80 | 153 | 31 | 5.71 ± 0.18 | 92.11 ± 1.87 | 183.97 ± 6.74 | 36.47 ± 1.78 | TT | 61 (25–84) | 55 : 27 | 41 | 20 | 18 | 3 | 0 | 0 | 0 | 10 | 35 | 37 | 23 | 23 | 36 | 70 | 12 | 5.87 ± 0.28 | 93.03 ± 2.89 | 167.34 ± 8.26 | 36.99 ± 2.63 | | 0.175 | 0.524 | | 0.18 | | | | | 0.016 | 0.01 | 0.437 | 0.022 | 0.331 | 0.598 | 0.41 | | 0.608 | 0.109 | | 0.512 | | | | | 0.446 | 0.647 | 0.647 | 0.023 | 0.324 | 0.758 | 0.475 | NF-κB-94 ind/del (rs28362491) | Ins/ins | 60 (25–89) | 77 : 53 | 61 | 28 | 36 | 3 | 0 | 1 | 0 | 8 | 48 | 74 | 25 | 51 | 54 | 103 | 27 | 6.7 ± 0.10 | 100.4 ± 0.23 | 219.61 ± 0.54 | 49.99 ± 0.37 | Ins/del | 60 (25–80) | 98 : 62 | 69 | 37 | 48 | 6 | 1 | 0 | 0 | 2 | 65 | 93 | 18 | 61 | 81 | 135 | 25 | 6.76 ± 0.10 | 97.57 ± 0.21 | 222.37 ± 0.59 | 51.39 ± 0.30 | Ins/del | 58 (29–77) | 42 : 23 | 33 | 9 | 23 | 0 | 0 | 0 | 0 | 1 | 24 | 40 | 7 | 33 | 25 | 57 | 8 | 6.69 ± 0.19 | 96.32 ± 0.33 | 215.13 ± 0.88 | 54.36 ± 0.40 | | 0.306 | 0.767 | | 0.059 | | | | | 0.155 | 0.096 | 0.28 | 0.062 | 0.266 | 0.561 | 0.036 | | 0.352 | | | | | | 0.38 | 0.324 | 0.601 | 0.19 | IL-1β (rs16944) | GG | 60 (28–89) | 66 : 37 | 46 | 18 | 35 | 4 | 0 | 0 | 0 | 3 | 36 | 64 | 14 | 39 | 50 | 88 | 15 | 6.77 ± 0.12 | 95.80 ± 0.26 | 220.61 ± 0.70 | 52.1 ± 0.39 | AG | 60 (25–84) | | 76 | 35 | 47 | 3 | 1 | 1 | 0 | 6 | 72 | 84 | 24 | 72 | 66 | 131 | 31 | 6.52 ± 0.09 | 101.35 ± 0.21 | 224.19 ± 0.52 | 50.55 ± 0.31 | AA | 59 (35–79) | | 41 | 21 | 25 | 2 | 0 | 0 | 0 | 4 | 29 | 57 | 12 | 34 | 44 | 76 | 14 | 7.04 ± 0.15 | 95.80 ± 0.25 | 211.43 ± 0.77 | 52.37 ± 0.36 | | 0.338 | 0.317 | | 0.84 | | | | | 0.303 | 0.681 | 0.579 | 0.462 | 0.738 | 0.503 | 0.525 | | 0.995 | | | | | | 0.245 | 0.156 | 0.588 | 0.322 | IL-18 (rs1946518) | GG | 58 (29–91) | 58 : 33 | 43 | 15 | 31 | 1 | 0 | 0 | 0 | 2 | 34 | 55 | 11 | 37 | 43 | 79 | 12 | 6.87 ± 0.13 | 95.12 ± 0.29 | 211.40 ± 0.38 | 52.62 ± 0.38 | GT | 60 (28–89) | 107 : 78 | 85 | 37 | 55 | 7 | 1 | 1 | 0 | 7 | 68 | 110 | 28 | 73 | 84 | 154 | 31 | 6.57 ± 0.09 | 97.83 ± 0.19 | 218.92 ± 0.52 | 51.17 ± 0.28 | TT | 61.5 (25–79) | 52 : 27 | 35 | 22 | 21 | 1 | 0 | 0 | 0 | 4 | 35 | 40 | 11 | 35 | 33 | 62 | 17 | 6.94 ± 0.15 | 103.15 ± 0.29 | 232.36 ± 0.85 | 51.12 ± 0.45 | | 0.399 | 0.399 | | 0.422 | | | | | 0.604 | 0.908 | 0.351 | 0.395 | 0.03 | 0.951 | 0.496 | | 0.168 | | | | | | 0.429 | 0.249 | 0.839 | 0.987 |
|
|
, values of homozygous polymorphisms. , values of heterozygous polymorphisms. |